Genetic and epigenetic control of RKIP transcription
Affiliations
Affiliations
- Department of Biochemistry and Cancer Biology, University of Toledo, College of Medicine, Health Science Campus, Toledo, Ohio.
- Faculty of Medicine, Department of Pathology, Kuwait University Health Sciences Centre, Safat, Kuwait.
- Kuwait University, Faculty of Medicine, Safat, Kuwait.
Abstract
Raf kinase inhibitory protein (RKIP) is known to modulate key signaling cascades and regulate normal physiological processes such as cellular proliferation, differentiation, and apoptosis. The expression of RKIP is found to be downregulated in several cancer metastases and the repressed RKIP expression can be reactivated on treatment with chemotherapeutic agents. RKIP is a proven tumor metastasis suppressor gene and investigating the mechanisms of transcriptional regulation of RKIP is therefore of immense clinical importance. In this review, we discuss the basal expression of RKIP in various tissues and the genetic aspects of the RKIP chromosomal locus including the structure of the RKIP promoter as well as gene regulatory elements such as enhancers. We also review the genetic and epigenetic modulation of RKIP transcription through EZH2, a component of the polycomb repressive complex 2 (PRC2) and sequence specific transcription factors (TFs) BACH1 and Snail. Emerging experimental evidence supports a unifying model in which both these TFs repress RKIP transcription in cancers by recruiting the EZH2 containing repressive complex to the proximal RKIP promoter. Finally, we review the known mechanisms employed by different types of chemotherapeutic agents to activate RKIP expression in cancer cells.
Similar articles
Lai TH, Ahmed M, Hwang JS, Zada S, Pham TM, Elashkar O, Kim DR.Int J Mol Sci. 2021 Mar 17;22(6):3052. doi: 10.3390/ijms22063052.PMID: 33802672 Free PMC article.
Snail is a repressor of RKIP transcription in metastatic prostate cancer cells.
Beach S, Tang H, Park S, Dhillon AS, Keller ET, Kolch W, Yeung KC.Oncogene. 2008 Apr 3;27(15):2243-8. doi: 10.1038/sj.onc.1210860. Epub 2007 Oct 22.PMID: 17952120 Free PMC article.
Lee J, Lee J, Farquhar KS, Yun J, Frankenberger CA, Bevilacqua E, Yeung K, Kim EJ, Balázsi G, Rosner MR.Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):E364-73. doi: 10.1073/pnas.1304840111. Epub 2014 Jan 6.PMID: 24395801 Free PMC article.
Wu K, Bonavida B.Crit Rev Immunol. 2009;29(3):241-54. doi: 10.1615/critrevimmunol.v29.i3.40.PMID: 19538137 Review.
A New Linkage between the Tumor Suppressor RKIP and Autophagy: Targeted Therapeutics.
Wang Y, Bonavida B.Crit Rev Oncog. 2018;23(5-6):281-305. doi: 10.1615/CritRevOncog.2018027211.PMID: 30311561 Free PMC article. Review.
References
https://pubmed.ncbi.nlm.nih.gov/